Alpha Profiles · Company Profile

Disc Medicine, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/disc-medicine-inc

Entity: Public listing published
Primary listing: NASDAQ: IRON
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:49.108375+00:00

Overview

Alpha's canonical identity and public leadership record for Disc Medicine, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Jean Franchi

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

John Quisel, J.D., Ph.D.

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

Jonathan Yu, M.B.A.

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

Pamela Stephenson, M.P.H.

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

Rahul Khara, Pharm.D., J.D.

Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

Wenbin Jiang, Ph.D.

Named Executive Officer

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: IRON DEF 14A executive officersApr 28, 2026

William Savage, M.D., Ph.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187646Apr 28, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.